Japanese company to develop CBD oil from orange peel
Over the past few days, a strange piece of news has been spreading: a Japanese company has reportedly presented prototypes of its oil CBD orange peel extract.
Hiro International specializes in importing fruit and fruit juices for the Japanese market, as well as developing and distributing banana extract, horse placenta extract and kidney bean extract for the food, pharmaceutical and cosmetics industries, would have presented at the Cosme Tokyo trade show in January 2020, a line of CBD oil derived from orange peel.
Hiro International spokesman Ryosuke Koseki is quoted as saying that 'Orange CBD» would be structurally identical to hemp-derived CBD, offering the same relaxing and skin-nourishing benefits. »With Orange CBD, you get the same ingredient, the same effects and there's no danger in terms of legality. It also provides a different CBD story for the consumer that sounds better than being derived from the cannabis plant.«.
He reportedly added that there have been no studies to compare Orange CBD to hemp-derived CBD, but that the company may be thinking about it soon.
Contacted by us, the company has not yet replied. However, there is no mention of the product on their website, and apart from a few press releases dated February, the only news item to mention this strange product was a recent article in Hanf Magazine.
Can CBD be extracted from citrus fruit?
If the CBD can be found in other plants than Cannabaceae and in lesser quantities, we have found no studies to date documenting the presence of CBD in oranges.
Nevertheless, the peels could have been used to synthesize CBD.
The American company Citrus CBD, founded in 2018 in Oregon, markets synthesized CBD, for example. from citrus peels, an evergreen tree and 'a proprietary scientific process» they call Cyclic Terpene Assembly (CTA). In simple terms, CBD is recreated from orange and pine terpenes.
These citrus-derived CBD molecules are theoretically identical to the CBD molecules derived from cannabis.
What's in it for me? Certainly not the price. Extracting CBD from hemp is relatively inexpensive. Conversely, synthesizing CBD is expensive, both in terms of R&D and operational costs. The advantage of CBD not extracted from hemp is the molecule's legality, as it falls outside the international cannabis regime, and the absence of THC.
«Some companies have run into huge problems because THC has been detected in their products,» explains Koseki.
Japan's cannabis legislation, despite a history of hemp that permeates the whole country, is still one of the strictest in the world. Synthetic CBD thus avoids potential regulatory worries.
-
Cannabis in France4 weeks ago
France Sets July as the Deadline for the Widespread Adoption of Medical Cannabis
-
Cannabis in Europe2 weeks ago
Bosnia and Herzegovina Continues to Roll Out Medical Cannabis Following Its Legalization
-
Cannabis in France2 weeks ago
France Submits the Long-Awaited Decree on the Reimbursement of Medical Cannabis to the Council of State
-
Cannabis in the U.S.2 weeks ago
The DEA Begins Hearings on the Federal Rescheduling of Cannabis
-
Cannabis in Ireland3 weeks ago
The Irish Parliament recommends decriminalizing all drugs
-
Business4 weeks ago
Sanity Group is expanding its presence in Switzerland through a distribution agreement with Astrasana
-
Cannabis in France4 weeks ago
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
-
Cannabis in Switzerland3 weeks ago
St. Gallen, Switzerland, Launches Its 8th Legal Cannabis Pilot Project


You must be logged in to post a comment Login